ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FIRST QUARTER 2018

Good sales growth during the first quarter; Revenue increased 7% compared with the previous year.

Zinzino’s total revenues for the first quarter of 2018 amounted to 137.0 (128.2) MSEK, corresponding to sales growth of 7% compared to the first quarter 2017.
Several markets showed strong growth. The new European markets increased 175% in total. The increase was especially strong in Hungary where the sales amounted to 2.7 (0.1) MSEK during the first quarter. Germany increased by 108%. In the Baltic countries, the strong sales growth continued in Latvia which increased by 58%. The high turnover markets Sweden and Finland increased by 18% and 10%, respectively, during the first quarter.

* Comparative figures adjusted per the new accounting policy regarding currency-related income and expenses

For more information: 
Dag Bergheim Pettersen, CEO Zinzino, Mobile: +47 (0) 932 25 700 www.zinzino.com

Pictures for publication free of charge: Marcus Tollbom, Mobile: +46 (0) 70 190 03 12 
 
Certified Adviser:
Erik Penser Bank Aktiebolag  

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 13.00 on 10th of April, 2018.

Zinzino AB (publ.) is a direct sales company that operates throughout Europe and North America. Zinzino markets and sells prod­ucts in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns the Norwegian company BioActie Foods AS and the research and production unit Faun Pharma AS. Zinzino has more than 120 employees and currently trades in 33 markets across Europe and North America. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, Oslo, and in Florida, USA. Zinzino is a public company and its shares are listed on Nasdaq First North. In 2016, Zinzino was recognized with the award ‘’Superföretag 2015’’ by Veckans Affärer and the ‘’Gazelle’’ award by Dagens Industri.

Tags:

About Us

Zinzino AB (publ.) is a direct sales company which operates through the EU, Norway, Iceland and in North America. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns Norwegian BioActive Foods AS and the research and production unit Faun Pharma AS. Zinzino has over 120 employees. The company has its registered office in Gothenburg, and offices in Helsinki, Riga, Oslo and in Florida, United States. Zinzino is a public limited company and its shares are listed on Nasdaq First North.

Subscribe

Documents & Links